Related Experiment Video
Updated: Mar 13, 2026

Four-Dimensional Computed Tomography-Guided Valve Sizing for Transcatheter Pulmonary Valve Replacement
Published on: January 20, 2022
TAVI for aortic regurgitation - India's first case with Corevalve Evolut R
A B Gopalamurugan1, K Murali2, B Jyotsana3
1Chief of Department of Percutaneous Valves, ICAAD, India.
Abstract:
Transcatheter Aortic Valve Implantation (TAVI) is a well-described treatment for symptomatic calcific severe aortic stenosis. However, TAVI technology is being increasingly used around the world to treat selected cases of severe aortic regurgitation (AR). One of the main limitations of using TAVI technology for AR is the lack of calcification, which is common in such cases. This makes anchoring of a TAVI prosthesis to the aortic annulus difficult and risks displacement or embolization. However, with the availability of recapturable and repositionable TAVI technologies, these limitations have been overcome to a large extent. This is the first Corevalve Evolut R device that was used in India and the first TAVI to treat AR in India.
Related Concept Videos
Aortic Regurgitation I: Introduction
Aortic Regurgitation III: Medical Management
Mitral Regurgitation I: Introduction
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Aortic Regurgitation IV: Nursing Management
Mitral Regurgitation III: Medical Management

